# Study Enabling the Collection of Clinical Data Necessary for the Second Phase of Development of the Glycemic Measurement Device by Analysis of Exhaled Air

> **NCT06614101** · NA · RECRUITING · sponsor: **University Hospital, Toulouse** · enrollment: 235 (estimated)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **OTHER:** Exhaled air analysis

## Key facts

- **NCT ID:** NCT06614101
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-11
- **Primary completion:** 2026-05-31
- **Final completion:** 2026-05-31
- **Target enrollment:** 235 (ESTIMATED)
- **Last updated:** 2024-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06614101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06614101, "Study Enabling the Collection of Clinical Data Necessary for the Second Phase of Development of the Glycemic Measurement Device by Analysis of Exhaled Air". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT06614101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*